With the arrival of the Human Papillomavirus (HPV) vaccines and the progressive introduction of HPV-based screening technology, the field of cervical cancer prevention is expanding into new areas of influence involving an ever-widening group of professionals. Starting with the offer of HPV vaccines to pre-adolescent girls and the optional vaccination of young and middle-age women, HPV vaccines may in some instances be recommended as a universal vaccine for both genders towards the prevention of cervical cancer. "An unprecedented and phenomenal challenge for Public Health in the 21st century", according to Dr. Xavier Bosch, Guest Editor and driving force behind this monograph; "The background, the results, the challenges and a set of proposals are analyzed by a group of 100 independent experts, leaders in the various relevant fields".
This monograph was officially launched during the 23rd International Papillomavirus Conference & Clinical Workshop in Prague, Czech Republic at the beginning of September 2006. The full version is available at the Vaccine website (http://www.elsevier.com/locate/vaccine). Furthermore, this landmark publication will be available via the HINARI programme, the public-private initiative (launched by the World Health Organization) to bridge the digital divide in health information access (http://www.who.int/hinari/en/).